Dexcom Inc. executives may have thought a $30 million beat of the consensus estimates for third quarter revenue and 20% growth year-over-year provided a treat to shareholders, but investors seemed to ...

The activin E mechanism of action in obesity is having something of an early stage heyday with such players as Wave Life ...

Bowhead whales (Balaena mysticetus) live year-round in the icy or near-icy waters of the Arctic and sub-Arctic. Although they migrate with the seasonal cycles of ice formation and melting, they never ...

Scientists in the U.K. are developing glucose-powered bioelectronics to advance the use and capabilities of implantable medical devices. A research team, led by the University of Bath, received £2.1 ...

Vera Therapeutics Inc.’s atacicept gained still more airtime at the Cantor Fitgerald health care conference held Sept. 4, and some on Wall Street believe the appetite for the BAFF and APRIL dual ...

New hires and promotions in the biopharma industry, including: Aboleris, Akari, Alethio, Brenig, Cartesian, Tolremo, Valanx.

E and INHBE-targeting WVE-007, a GalNAc-siRNA therapy for obesity. The phase I study called Inlight turned up potent, durable, and dose-dependent activin E reductions with single doses of WVE-007 in ...

Biopharma happenings, including deals and partnerships, and other news in brief: 89bio, Anavex, Everest Medicines, Insmed, Novabridge, Roche, Sensei, Visara.

University of Eastern Finland has synthesized carbonic anhydrase II (CA2) inhibitors and melanin ligands. As such, they are described as potentially useful for the treatment of glaucoma, macular edema ...

Boehringer Ingelheim GmbH has licensed an unnamed small-molecule preclinical candidate from Kyowa Kirin Co. Ltd. in the autoimmune disease space in a deal worth up to €640 million (US$739 million).

At the AACR-NCI-ORTC conference, researchers from Dewpoint Therapeutics Inc. presented advances in targeting MYC condensates, revealing a potential breakthrough strategy for treating cancers driven by ...

Hirsutism is the excessive hair growth in women in male-typical areas, usually associated with androgen excess and other conditions such as polycystic ovary... Primary open-angle glaucoma (POAG) is ...